First Trust Capital Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

First Trust Capital Management’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-107,737	Closed	-$2.3M	–	130
2024 Q1	$2.3M	Buy	+107,737	New	+$1.29M	0.2%	88

First Trust Capital Management's FUSN Position: Q2 2024 in Review

First Trust Capital Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 107,737 shares — an estimated $2.3M sold.

First Trust Capital Management first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $2.3M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

First Trust Capital Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
First Trust Capital Management sold 107,737 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $2.3M.
First Trust Capital Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
First Trust Capital Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $2.3M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on First Trust Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.